Effect of dose, molecular size, affinity, and protein binding on tumor uptake of antibody or ligand: a biomathematical model.

A mathematical model has been developed to determine the best approach to improving tumor targeting with antibody. The amount of antibody in the tumor (tumor content) and the tumor:normal tissue antibody concentration ratio (uptake ratio) were calculated over 12 days from injection, using the computer program FACSIMILE to solve the stiff nonlinear differential equations describing the system. Results indicate that success requires an optimal combination of dose, size, and binding affinity of antibody. Increasing the dose to 100 times that presently used for scanning increased both the percentage of injected antibody in the tumor and the uptake ratio by up to 2 orders of magnitude to maximal values determined by affinity. This result could be achieved by coinjecting unlabeled antibody. Increasing affinity from Keq = 10(9) to 10(13)M-1 increased the uptake ratio from 5 to 100 for whole antibody and to 550 for a small ligand, at the calculated optimal dose, but had no effect at the current scanning dose. With decreasing molecular size at average affinity, the same maximum tumor content and uptake ratio were achieved but progressively earlier. At high affinity there was a substantial advantage for a small ligand compared with whole antibody in terms of uptake ratio (550 versus 100) and tumor:normal tissue integral dose ratio (330 versus 60). The uptake of a small ligand was not increased by binding to plasma protein but with increasing time the tumor content was higher than without protein binding.

[1]  C. Crone,et al.  The penetration of inulin, sucrose, mannitol and tritiated water from the interstitial space in muscle into the vascular system , 1970, The Journal of physiology.

[2]  H. Davson,et al.  Introduction to Physiology , 1948 .

[3]  M L Yarmush,et al.  Dissociation kinetics of antigen-antibody interactions: studies on a panel of anti-albumin monoclonal antibodies. , 1989, Molecular immunology.

[4]  R K Jain,et al.  Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.

[5]  A. Vaughan,et al.  Limiting factors in the localization of tumours with radiolabelled antibodies. , 1985, Immunology today.

[6]  J N Weinstein,et al.  Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice. , 1986, Cancer research.

[7]  J. Papadimitriou,et al.  Structural and functional characteristics of the microcirculation in neoplasms , 1975, The Journal of pathology.

[8]  Van Oss Cj,et al.  The nature of the antigen-antibody bond and the factors affecting its association and dissociation. , 1986 .

[9]  R. Jain,et al.  Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.

[10]  Lawrence F. Shampine,et al.  A User’s View of Solving Stiff Ordinary Differential Equations , 1979 .

[11]  M. Strand,et al.  Radiolabeled antibody: iodine versus radiometal chelates. , 1987, NCI monographs : a publication of the National Cancer Institute.

[12]  M. Sela,et al.  Shape and volume of fragments Fab' and (Fab')2 of anti-poly(D-alanyl) antibodies in the presence and absence of tetra-D-alanine as determined by small-angle x-ray scattering. , 1975, Biochemistry.

[13]  S. I. Rubinow.  Mathematical Problems in the Biological Sciences , 1987 .

[14]  R. E. Gosselin,et al.  Capillary permeability in the isolated rabbit heart as measured by local tissue clearance. , 1984, Microvascular research.

[15]  K. Arfors,et al.  Microvascular transport of macromolecules in normal and inflammatory conditions. , 1979, Acta physiologica Scandinavica. Supplementum.

[16]  P. Gullino,et al.  Diffusion and convection in normal and neoplastic tissues. , 1974, Cancer research.

[17]  M. Steward,et al.  Antibody affinity : thermodynamic aspects and biological significance , 1983 .

[18]  Y. Kim,et al.  Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines. , 1983, Cancer research.

[19]  G. Lundborg,et al.  Capillary permeability of two transplantable rat tumours as compared with various normal organs of the rat. , 1973, Bibliotheca anatomica.

[20]  Beathard Ga.  Proteinuria and the nephrotic syndrome. , 1973 .

[21]  D. Kufe,et al.  Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. , 1980, Cancer research.

[22]  B. Gallagher,et al.  Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In. , 1987, Cancer research.

[23]  K. Foon,et al.  Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  A. Vaughan,et al.  Radioimmunotherapy of cancer: clinical studies and limiting factors. , 1987, Cancer treatment reviews.

[25]  J. Mach,et al.  Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues. , 1973, Immunochemistry.

[26]  J. Jacquez.  Compartmental analysis in biology and medicine , 1985 .

[27]  L. Heuser,et al.  Differential macromolecular leakage from the vasculature of tumors , 1986, Cancer.

[28]  F. Karush.  The Affinity of Antibody: Range, Variability, and the Role of Multivalence , 1978 .

[29]  L. Chatenoud,et al.  Antigenic modulation - a major mechanism of antibody action. , 1984, Immunology today.

[30]  E. M. Renkin,et al.  Transport of large molecules from plasma to interstitial fluid and lymph in dogs. , 1970, The American journal of physiology.

[31]  E. P. Krenning,et al.  LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN , 1989, The Lancet.

[32]  J. Taylor‐Papadimitriou,et al.  Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. , 1986, Cancer research.

[33]  H. Hikita,et al.  The computerized derivation of rate equations for enzyme reactions on the basis of the pseudo-steady-state assumption and the rapid-equilibrium assumption. , 1988, The Biochemical journal.

[34]  D. Goldenberg,et al.  Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model. , 1988, Cancer research.

[35]  J. DiStefano,et al.  Computer simulation of thyroid hormone binding, distribution, and disposal dynamics in man. , 1971, The American journal of physiology.

[36]  I. Carr,et al.  The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma , 1972, The Journal of pathology.

[37]  J. Shuster,et al.  Heterogeneity of the protein moiety of carcinoembryonic antigens. , 1976, Immunological communications.

[38]  G. Denardo,et al.  Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancer. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.